- Open Access
Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission
© Ngandu et al; licensee BioMed Central Ltd. 2009
- Received: 1 September 2009
- Accepted: 10 October 2009
- Published: 10 October 2009
The cytotoxic T-lymphocyte immune response is important in controlling HIV-1 replication in infected humans. In this immune pathway, viral peptides within infected cells are presented to T-lymphocytes by the polymorphic human leukocyte antigens (HLA). HLA alleles exert selective pressure on the peptide regions and immune escape mutations that occur at some of the targeted sites can enable the virus to adapt to the infected host. The pattern of ongoing immune escape and reversion associated with several human HLA alleles has been studied extensively. Such mutations revert upon transmission to a host without the HLA allele because the escape mutation incurs a fitness cost. However, to-date there has been little attempt to study permanent loss of CTL epitopes due to escape mutations without an effect on fitness.
Here, we set out to determine the extent of adaptation of HIV-1 to three well-characterized HLA alleles during the initial exposure of the virus to the human cytotoxic immune responses following transmission from chimpanzee. We generated a chimpanzee consensus sequence to approximate the virus sequence that was initially transmitted to the human host and used a method based on peptide binding affinity to HLA crystal structures to predict peptides that were potentially targeted by the HLA alleles on this sequence. Next, we used codon-based phylogenetic models to quantify the average selective pressure that acted on these regions during the period immediately following the zoonosis event, corresponding to the branch of the phylogenetic tree leading to the common ancestor of all of the HIV-1 sequences. Evidence for adaptive evolution during this period was observed at regions recognised by HLA A*6801 and A*0201, both of which are common in African populations. No evidence of adaptive evolution was observed at sites targeted by HLA-B*2705, which is a rare allele in African populations.
Our results suggest that the ancestral HIV-1 virus experienced a period of positive selective pressure due to immune responses associated with HLA alleles that were common in the infected human population. We propose that this resulted in permanent escape from immune responses targeting unconstrained regions of the virus.
- Human Leukocyte Antigen
- Human Leukocyte Antigen Allele
- Human Leukocyte Antigen Molecule
- Chimpanzee Sequence
- Positive Selective Pressure
Phylogenetic analysis indicates that the human immunodeficiency virus type 1 (HIV-1) originated from simian immunodeficiency virus infecting chimpanzees (SIVcpz) through a chimpanzee-to-human zoonotic transmission [1–4]. Until recently , the natural hosts of the virus, the chimpanzee, have been thought to remain asymptomatic throughout infection despite high viral loads [6–8] In humans, however, an increase in viral load is usually associated with progression to the acquired immuno-deficiency syndrome (AIDS) and subsequently death [9–13]. The causes of the difference in disease progression may involve either differences in the host and/or between the HIV-1 and the SIVcpz viruses.
A zoonotic (i.e. cross-species) event is expected to be accompanied by mutations that enable the pathogen to adapt to the new host environment, (e.g. as observed in a study by Baric et al ). Indeed, sequence changes have been identified in HIV-1 that are evidence of selective pressure associated with the genetics of the human host [15–17]. In particular, the human cytotoxic T-lymphocyte (CTL) immune response directed against foreign antigens plays a major role in exerting selective pressure on antigenic proteins, including those of HIV-1. The activation and characteristics of the immune responses against the virus have been found to differ remarkably between human and chimpanzee [7, 18–20]: an elevated anti-HIV immune response upon infection is characteristic in humans, but the chimpanzee generally maintains a low level of immune activation. The human immune response may therefore exert higher selective pressure on the virus sequence compared to immune responses of the natural host. However, the virus is capable of overcoming the immune response, leading to AIDS.
The CTL immune response is mediated by Human Leukocyte Antigen (HLA) molecules that bind to endogenous antigenic peptides known as epitopes, and transport them to the surface of the infected cell for recognition by CTLs resulting in killing of the infected cell . The HLA gene is highly polymorphic and each HLA molecule binds to peptides that contain specific sequence motif patterns (known as anchor residue motifs) [22, 23]. For binding to occur between a peptide and the HLA binding groove, only limited amino acid variation at the main anchor positions of the peptide is allowed [21, 24, 25]. Successful binding, efficient transport and presentation of a peptide to a CTL depend on the presence of the appropriate anchor residue motif and the overall affinity between the HLA binding groove and the epitope [26, 27]. The strength of selective pressure varies between specific CTL immune responses directed by different HLA alleles . Some HLA molecules have been associated with immune escape mutations at anchor sites which enable the virus to adapt to the host, thus increasing viral load [8, 29–31].
Investigation of the evolutionary dynamics of immune escape has focussed primarily on escape mutations that incur a fitness cost and consequently revert to wild type, upon transmission to a host that mounts different immune responses. This can result in a pattern of toggling between escape and wild-type amino acids that is detectable using evolutionary modelling . In this study the focus is on escape mutations that do not incur a cost in terms of viral fitness. Such escape mutations do not experience selection pressure to revert to the wild-type state following transmission to a new host. Consequently, they are associated with episodic selection, rather than the ongoing rapid evolution associated with escape and reversion. Upon transmission to human, SIV is likely to have experienced selective pressure to escape from common human immune responses. Some of these escape mutations would not have had a significant effect on the fitness of the virus and thus would not have experienced strong selection to revert. Consequently, we hypothesized that the branch of the SIV-HIV-1 phylogenetic tree leading to the ancestor of the HIV-1 sequences would include evidence of episodic selection to escape from common HLA alleles.
To investigate the evidence of episodic selection for CTL escape along this branch, we predicted epitopes for HLA alleles, using the SIV consensus sequence to approximate the sequence that was transmitted to humans. We used a structure-based method that estimates the strength of binding between a viral amino acid sequence and an HLA molecule from amino acid pair-wise potentials for the epitope prediction. We selected regions where known anchor residue motifs were present and which had high binding affinity, limiting our analysis of selective pressure to these regions. Finally, we used models of codon sequence evolution to quantify the selective pressure, inferring positive selection from the ratio of nonsynonymous substitution rates (dN) to synonymous substitution rates (dS) for individual branches in a phylogeny. Branch-specific analysis of selective pressure enabled us to investigate selective pressure along the branch ancestral to the HIV sequences, and hence to study how HIV-1 adapted to the human host upon transmission from chimpanzee.
Predicting HLA binding regions
We used PREDEP , a structure-based method for predicting HLA binding peptides to determine potential binding regions across the genome. We used the consensus chimpanzee sequence to predict the best HLA binding regions because it has not been exposed to selective pressure resulting from human HLA and approximates the sequence that was transmitted to human. Consequently, it may be possible to detect epitopes in the chimpanzee sequence that were eliminated from HIV-1 shortly after transmission to humans. PREDEP does not require knowledge of known HLA-binding peptides. The program requires solved crystal structures of the HLA molecules as well as knowledge of amino acid residues on the HLA binding groove that interact with each position of the antigenic peptide sequence. Amino acid pair-wise potentials between the peptide and the amino acids in the HLA binding groove are calculated based on backbone and side-chain interactions.
A score for each HLA-peptide interaction is calculated as the sum of amino acid pair-wise potentials between each peptide residue and the interacting residues of the HLA binding groove. The lower the score, the better the peptide binds to the HLA binding groove, i.e., the higher the binding affinity. Peptides with strong binding affinities to the HLA molecule are most likely to be successfully presented to CTLs in-vivo. A test of PREDEP performance showed that 80% of the top 15 percentile best binders were known optimal HLA binding peptides . In this study, we determined the binding energy of all possible peptides across the SIVcpz consensus sequence to each of the six HLA alleles with known crystal structures available in PREDEP. For each available HLA allele, we first selected peptide regions that had binding scores in the best 5% (a conservative threshold chosen to ensure minimal false positives) of those obtained across the chimpanzee sequence for that particular HLA allele. Next, we discarded regions that did not contain the amino acid residues known to give optimal binding at the major binding pockets, i.e. peptides that matched the anchor residue motifs of the HLA allele. For each HLA allele, we generated a new alignment consisting of only the sites in the potential binding regions identified for that allele for further analysis.
Analysis of Selective pressure along the HIV-1 ancestral branch
We used the BranchAPriori  and GABranch  algorithms implemented in HyPhy  to analyse branch-specific selective pressure exerted by each HLA allele. We were specifically interested in selective pressure along the SIVcpz branch ancestral to the HIV-1 sequences (labelled 'B' in Figure 1, and referred to below as the HIV ancestral branch), because we expect that this reflects the evolution of the virus around the time of transmission from chimpanzees to human. We therefore investigated whether there is higher selective pressure on this branch at sites that are potential targets for each HLA allele under study. These two approaches calculate the average selective pressure acting upon all regions potentially targeted by an HLA allele, thus combining evidence from multiple sites. We expect that this should result in more powerful tests than can be obtained via site-specific analysis.
The BranchAPriori analysis
For each HLA-related alignment described in the previous section, we compared the selective pressure along the HIV ancestral branch to the rest of the branches in the tree using the BranchAPriori algotithm. The program outputs a p-value derived from the difference in the log likelihood between the null and the alternative models. The null model assumes a single global dN/dS ratio (ω) across the tree; in the alternative model, ω is allowed to have a different value for the HIV ancestral branch.
The a priori analysis has the disadvantage of assuming that all the branches in the rest of the tree are under uniform selective pressure. This could result in the analysis having reduced power, for instance when there is strong among-branch heterogeneity of selective pressure in the rest of the tree .
The GABranch analysis
In order to construct a more realistic null model, we therefore considered models that allow selective pressure to vary across all branches of the tree. We used GABranch , a genetic algorithm implemented in HyPhy, to infer branch-specific selective pressure across the entire phylogeny of SIV and HIV-1 sequences and determine, for each of the potential HLA binding regions, whether it evolved under positive selection in the HIV ancestral branch.
Prediction of HLA binding regions in the chimp sequence
HLA class 1 alleles with available crystal structure
Allele frequency in African population
Sequence data for the regions predicted to have potential HLA binding peptides
Anchor residue motif1
Predicted HLA binding regions
BranchAPriori analysis of differential selection between the HIV and SIV lineages
BranchApriori ω values for the HIV ancestral branch and the rest of the tree
HIV ancestral branch ω
Rest of the tree ω
Branch-by-branch analysis of selective pressure using the GABranch algorithm
The best fitting models and model-averaged results obtained by the GABranch analysis
Best fitting model: ω rate classes (number of branches)1
Model-averaged ω for HIV ancestral branch2
Model-averaged Prob(dN>dS)3 for HIV ancestral branch
1.14 (33), 0.62 (46)
1.15 (42), 0.60 (31), 0.23(6)
For HLA A*6801 (Figure 3), positive selective pressure was inferred along the HIV ancestral branch (ω = 1.15). A very high proportion of the tested models (0.996) supported dN>dS along this branch. We also found positive selective pressure along the HIV ancestral branch for HLA A*0201 (ω = 1.14, Figure 2) and again 0.996 of models supported for dN>dS. The best fitting model for the HLA B*2705 predicted binding sites had only a single rate class under weak purifying selection, and support for dN>dS was not obtained on any branch of the phylogeny (Figure 4). These results are consistent with those of the BranchAPriori analysis and suggest that HLA A*0201 and HLA A*6801 exerted positive selective pressure on the HIV-1 sequence in the period immediately following zoonosis, whereas HLA B*2705 did not exert strong selective pressure on the HIV-1 sequence at any point in the phylogeny.
The PREDEP program provides binding predictions for a limited number of HLA molecules with solved crystal structures and preferred binding anchor residue motifs that were predicted from HLA-peptide structural conformations. Only six such HLA alleles known to mediate cytotoxic T-lymphocyte immune responses are available for analysis. Amongst these, we only observed HLAs A*0201, A*6801 and B*2705 to bind strongly to some regions of the consensus SIVcpz genome. Our analysis was therefore restricted to selective pressure potentially exerted by each of these three alleles following the chimpanzee-to-human zoonosis event of HIV.
It is interesting that neither the a priori nor the GABranch analysis found evidence for positive selection in the HLA B*2705 alignment, whether along the ancestral HIV-1 branch or any other branch. This is surprising because B27 alleles have been associated with delayed progression to AIDS in HIV-1 infected individuals , which in turn is associated with persistent strong positive selection at specific sites . Also, delayed progression is a result of reduced viral replication - this indicates that these sites are important for the fitness of the virus. One possibility that could explain the observed HLA B*2705 result is that it may have caused positive selection on only a few sites. Such selection is hard to detect because ω is averaged over all sites of the sequence. Selection may also have been weak due to the fact that this is a rare HLA allele (1%) .
In the HLA A*0201 dataset, both the a priori and the GABranch analyses inferred positive selection on the HIV-1 ancestral branch, with very high support for dN>dS. Of the alleles available for analysis in this study, HLA A*0201 is the most frequent in African populations (see Table 1). It is also the most frequent HLA allele in Caucasian populations and many studies have been carried out to determine its effect on HIV disease progression . Even though the allele recognizes immunodominant peptide regions of the HIV-1 sequence, it fails to exert strong selective pressure on some virus peptides . Some studies have also shown that the outcome of an immune response does not only depend on the HLA molecule but also on the specific peptide sequences that are targeted [44–48]. Our results suggest that immune escape mutations that occurred for HLA A*0201 mediated CTL responses may have been selected for in the period immediately following zoonosis. If these adaptations subsequently became fixed in the viral population they would no longer be under diversifying selection today.
HLA A*6801 (another common allele in African populations) appears to have exerted strong selective pressure on the HIV-1 ancestral branch compared to the rest of the tree. High support (99.6% of the tested models) for ω > 1 was observed at the ancestral HIV branch. This allele has anchor residue motif restrictions that are shared within the HLA A3 supertype, the second most frequent supertype in the human population . The HLA A*6801 allele itself targets the Tat protein, which is expressed in the early stages of the HIV-1 lifecycle, and CTL responses to this protein cause a significant reduction in disease progression rate . Escape mutations from the CTL immune response have also been identified within Tat at the population level, causing reduced viral load [51, 52]. The virus may have adapted well to the A*6801 responses early after the cross-species transmission event at sites that do not affect the replication of the virus. The recently observed association with a reduction in viral load indicates that there were also functionally important sites contained in A*6801 epitopes - this would have made it difficult for these regions to adapt to the immune response.
This is the first study that analyses HLA-associated selective pressure following the transmission from chimpanzee to human across all potential target sites of the HIV-1 genome. We identified regions of the HIV-1 sequence that were initially targeted by the CTL immune response immediately after the cross-species transmission of HIV-1 from chimpanzee to human using the chimpanzee consensus sequence. Of the six HLA alleles with crystal structures available for analysis, we found strong binding regions; this could imply successful immune responses in vivo, for HLAs A*0201, A*6801 and B*2705. We determined the average extent of selective pressure exerted by each HLA allele along the branch leading to HIV-1 sequences. This branch represents the sequences that first encountered human immune response-directed selective pressure immediately following the zoonosis event. Our results suggest that HIV-1 adapted to CTL responses directed by HLAs A*6801 and A*0201, which are amongst the most common HLA genotypes in African populations (Table 1). It is therefore likely that the virus was frequently exposed to selective pressure exerted by common immune responses during initial exposure to the human host following transmission of the virus from chimpanzees. As observed from the results, we did not find evidence for strong selective pressure exerted by the HLA B*2705, which has extremely low frequencies in the African populations (Table 1) [53, 54].
In this study we focussed specifically on epitopes that we infer were likely to have been present in the viral sequence that first infected humans. We propose that the selection we observe at these positions along the branch of the phylogenetic tree leading to all of the HIV-1 sequences reflects episodic selection to evade human cytotoxic immune responses. Episodic selection has been proposed to be an important aspect of cross-species pathogen transmission and, in fact, observed in a laboratory setting previously . However, this is the first time, to our knowledge, that evidence has been presented of transient positive selection associated with human immune responses against unconstrained regions of the virus shortly after transmission to human.
This study was funded by the South African National Bioinformatics Network. NKN was supported by a training grant under the Stanford-South Africa Biomedical Informatics Training Program, which is supported by the Fogarty International Center, part of the National Institutes of Health (grant no. 5D43 TW006993).
- Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BH: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999, 397: 436-441. 10.1038/17130View ArticlePubMedGoogle Scholar
- Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD: An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998, 391: 594-597. 10.1038/35400View ArticlePubMedGoogle Scholar
- Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, Wolinsky S, Bhattacharya T: Timing the ancestor of the HIV-1 pandemic strains. Science 2000, 288: 1789-1796. 10.1126/science.288.5472.1789View ArticlePubMedGoogle Scholar
- Sharp P, Bailes E, Robertson D, Gao F, Hahn B: Origins and evolution of AIDS viruses. Biol Bull 1999, 196: 338-342. 10.2307/1542965View ArticlePubMedGoogle Scholar
- Keele BF, Jones JH, Terio KA, Estes JD, Rudicell RS, Wilson ML, Li Y, Learn GH, Beasley TM, Schumacher-Stankey J, Wroblewski E, Mosser A, Raphael J, Kamenya S, Lonsdorf EV, Travis DA, Mlengeya T, Kinsel MJ, Else JG, Silvestri G, Goodall J, Sharp PM, Shaw GM, Pusey AE, Hahn BH: Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 2009, 460: 515-519. 10.1038/nature08200PubMed CentralView ArticlePubMedGoogle Scholar
- Silvestri G, Paiardini M, Pandrea I, Lederman M, Sodora D: Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 2007, 117: 3148-3154. 10.1172/JCI33034PubMed CentralView ArticlePubMedGoogle Scholar
- Pandrea I, Ribeiro RM, Gautam R, Gaufin T, Pattison M, Barnes M, Monjure C, Stoulig C, Dufour J, Cyprian W, Silvestri G, Miller MD, Perelson AS, Apetrei C: Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J Virol 2008, 82: 3713-3724. 10.1128/JVI.02402-07PubMed CentralView ArticlePubMedGoogle Scholar
- Silvestri G: Immunity in natural SIV infections. Journal of INTERNAL MEDICINE 2008, 10: 1365-2796.Google Scholar
- Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ: Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997, 337: 1267-1274. 10.1056/NEJM199710303371803View ArticlePubMedGoogle Scholar
- Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, Barroso H, Taveira N, Rambaut A: Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 2007, 3: e29. 10.1371/journal.pcbi.0030029PubMed CentralView ArticlePubMedGoogle Scholar
- Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish LA: Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997, 336: 1337-1342. 10.1056/NEJM199705083361901View ArticlePubMedGoogle Scholar
- Saksela K, Stevens C, Rubinstein P, Baltimore D: Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci USA 1994, 91: 1104-1108. 10.1073/pnas.91.3.1104PubMed CentralView ArticlePubMedGoogle Scholar
- Michael NL, Mo T, Merzouki A, O'Shaughnessy M, Oster C, Burke DS, Redfield RR, Birx DL, Cassol SA: Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol 1995, 69: 1868-1877.PubMed CentralPubMedGoogle Scholar
- Baric RS, Yount B, Hensley L, Peel SA, Chen W: Episodic evolution mediates interspecies transfer of a murine coronavirus. J Virol 1997, 71: 1946-1955.PubMed CentralPubMedGoogle Scholar
- Wain LV, Bailes E, Bibollet-Ruche F, Decker JM, Keele BF, Van Heuverswyn F, Li Y, Takehisa J, Ngole EM, Shaw GM, Peeters M, Hahn BH, Sharp PM: Adaptation of HIV-1 to its human host. Mol Biol Evol 2007, 24: 1853-1860. 10.1093/molbev/msm110PubMed CentralView ArticlePubMedGoogle Scholar
- Soares AE, Soares MA, Schrago CG: Positive selection on HIV accessory proteins and the analysis of molecular adaptation after interspecies transmission. J Mol Evol 2008, 66: 598-604. 10.1007/s00239-008-9112-6View ArticlePubMedGoogle Scholar
- Choisy M, Woelk CH, Guegan JF, Robertson DL: Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol 2004, 78: 1962-1970. 10.1128/JVI.78.4.1962-1970.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Muller V, De Boer RJ: The integration hypothesis: an evolutionary pathway to benign SIV infection. PLoS Pathog 2006, 2: e15. 10.1371/journal.ppat.0020015PubMed CentralView ArticlePubMedGoogle Scholar
- Bibollet-Ruche F, McKinney BA, Duverger A, Wagner FH, Ansari AA, Kutsch O: The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype. J Virol 2008, 82: 10271-10278. 10.1128/JVI.01319-08PubMed CentralView ArticlePubMedGoogle Scholar
- Rutjens E, Balla-Jhagjhoorsingh S, Verschoor E, Bogers W, Koopman G, Heeney J: Lentivirus infections and mechanisms of disease resistance in chimpanzees. Front Biosci 2003, 8: d1134-d1145. 10.2741/1125View ArticlePubMedGoogle Scholar
- Madden DR, Gorga JC, Strominger JL, Wiley DC: The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992, 70: 1035-1048. 10.1016/0092-8674(92)90252-8View ArticlePubMedGoogle Scholar
- Rammensee H, Friede T, Stevanoviic S: MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41: 178-228. 10.1007/BF00172063View ArticlePubMedGoogle Scholar
- Saper MA, Bjorkman PJ, Wiley DC: Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991, 219: 277-319. 10.1016/0022-2836(91)90567-PView ArticlePubMedGoogle Scholar
- Ohno S: How cytotoxic T cells manage to discriminate nonself from self at the nonapeptide level. Proc Natl Acad Sci USA 1992, 89: 4643-4647. 10.1073/pnas.89.10.4643PubMed CentralView ArticlePubMedGoogle Scholar
- DiBrino M, Parker KC, Shiloach J, Turner RV, Tsuchida T, Garfield M, Biddison WE, Coligan JE: Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J Immunol 1994, 152: 620-631.PubMedGoogle Scholar
- Rovero P, Riganelli D, Fruci D, Vigano S, Pegoraro S, Revoltella R, Greco G, Butler R, Clementi S, Tanigaki N: The importance of secondary anchor residue motifs of HLA class I proteins: a chemometric approach. Mol Immunol 1994, 31: 549-554. 10.1016/0161-5890(94)90042-6View ArticlePubMedGoogle Scholar
- Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994, 153: 5586-5592.PubMedGoogle Scholar
- Carrington M, O'Brien SJ: The influence of HLA genotype on AIDS. Annu Rev Med 2003, 54: 535-551. 10.1146/annurev.med.54.101601.152346View ArticlePubMedGoogle Scholar
- Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, Andrieu JM, Schachter F, Zagury D, Rappaport J, Winkler C, Nelson GW, Zagury JF: New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999, 162: 6942-6946.PubMedGoogle Scholar
- Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, Feeney ME, Addo MM, Lichterfeld M, Lahaie MP, Pae E, Wurcel AG, Roach T, St John MA, Altfeld M, Marincola FM, Moore C, Mallal S, Carrington M, Heckerman D, Allen TM, Mullins JI, Korber BT, Goulder PJ, Walker BD, Brander C: Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 2006, 7: 173-178. 10.1038/ni1281View ArticlePubMedGoogle Scholar
- Honeyborne I, Prendergast A, Pereyra F, Leslie A, Crawford H, Payne R, Reddy S, Bishop K, Moodley E, Nair K, van der SM, McCarthy N, Rousseau CM, Addo M, Mullins JI, Brander C, Kiepiela P, Walker BD, Goulder PJ: Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol 2007, 81: 3667-3672. 10.1128/JVI.02689-06PubMed CentralView ArticlePubMedGoogle Scholar
- Delport W, Scheffler K, Seoighe C: Frequent toggling between alternative amino acids is driven by selection in HIV-1. PLoS Pathog 2008, 4: e1000242. 10.1371/journal.ppat.1000242PubMed CentralView ArticlePubMedGoogle Scholar
- Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, Wolinsky S, Korber B: HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 2005. 06-0680Google Scholar
- Ngandu NK, Scheffler K, Moore P, Woodman Z, Martin D, Seoighe C: Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences. Virol J 2008, 5: 160. 10.1186/1743-422X-5-160PubMed CentralView ArticlePubMedGoogle Scholar
- Kosakovsky Pond SL, Frost SD, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21: 676-679. 10.1093/bioinformatics/bti079View ArticleGoogle Scholar
- Altuvia Y, Margalit H: A structure-based approach for prediction of MHC-binding peptides. Methods 2004, 34: 454-459. 10.1016/j.ymeth.2004.06.008View ArticlePubMedGoogle Scholar
- Nielsen R, Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998, 148: 929-936.PubMed CentralPubMedGoogle Scholar
- Kosakovsky Pond SL, Frost SD: A genetic algorithm approach to detecting lineage-specific variation in selection pressure. Mol Biol Evol 2005, 22: 478-485. 10.1093/molbev/msi031View ArticleGoogle Scholar
- Yang Z: Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol Biol Evol 1998, 15: 568-573.View ArticlePubMedGoogle Scholar
- McNeil AJ, Yap PL, Gore SM, Brettle RP, McColl M, Wyld R, Davidson S, Weightman R, Richardson AM, Robertson JR: Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM 1996, 89: 177-185.View ArticlePubMedGoogle Scholar
- Ross HA, Rodrigo AG: Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol 2002, 76: 11715-11720. 10.1128/JVI.76.22.11715-11720.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Marsh S, Parham P, Barber L: The HLA Facts Book. Academic Press; 2000:1.Google Scholar
- Brander C, Hartman KE, Trocha AK, Jones NG, Johnson RP, Korber B, Wentworth P, Buchbinder SP, Wolinsky S, Walker BD, Kalams SA: Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest 1998, 101: 2559-2566. 10.1172/JCI2405PubMed CentralView ArticlePubMedGoogle Scholar
- Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, Baker B, Trocha A, Rosenberg R, Mackey E, Ueda P, Lu Z, Cohen D, Wrin T, Petropoulos CJ, Rosenberg ES, Walker BD: Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 2008, 197: 563-571. 10.1086/526786View ArticlePubMedGoogle Scholar
- Borghans JA, Molgaard A, De Boer RJ, Kesmir C: HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS ONE 2007, 2: e920. 10.1371/journal.pone.0000920PubMed CentralView ArticlePubMedGoogle Scholar
- Nelson GW, Kaslow R, Mann DL: Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Acad Sci USA 1997, 94: 9802-9807. 10.1073/pnas.94.18.9802PubMed CentralView ArticlePubMedGoogle Scholar
- Maurer K, Harrer EG, Goldwich A, Eismann K, Bergmann S, Schmitt-Haendle M, Spriewald B, Mueller SM, Harrer T: Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef. J Acquir Immune Defic Syndr 2008, 48: 133-141. 10.1097/QAI.0b013e31816fdc4aView ArticlePubMedGoogle Scholar
- Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, Brander C, Toth I, Arts EJ, Allen TM, Walker BD: HLA-B57/B*5801 HIV-1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong CTL Recognition. J Virol 2008, 10: 2265-2308.Google Scholar
- Sette A, Sidney J: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999, 50: 201-212. 10.1007/s002510050594View ArticlePubMedGoogle Scholar
- van Baalen CA, Pontesilli O, Huisman RC, Geretti AM, Klein MR, de Wolf F, Miedema F, Gruters RA, Osterhaus AD: Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J Gen Virol 1997,78(Pt 8):1913-1918.View ArticlePubMedGoogle Scholar
- Cao J, McNevin J, Malhotra U, McElrath MJ: Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection. J Immunol 2003, 171: 3837-3846.View ArticlePubMedGoogle Scholar
- Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothe BR, Vogel TU, Dunphy E, Liebl ME, Emerson C, Wilson N, Kunstman KJ, Wang X, Allison DB, Hughes AL, Desrosiers RC, Altman JD, Wolinsky SM, Sette A, Watkins DI: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000, 407: 386-390. 10.1038/35036559View ArticlePubMedGoogle Scholar
- Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E, Funkhouser R, Fugate M, Theiler J, Hsu YS, Kunstman K, Wu S, Phair J, Erlich H, Wolinsky S: Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003, 9: 928-935. 10.1038/nm893View ArticlePubMedGoogle Scholar
- Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, Sanchez-Mazas A, Thomson G: Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol 2008, 69: 443-464. 10.1016/j.humimm.2008.05.001PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.